Who Is Actually Deficient
Vitamin D deficiency — typically defined as a serum 25-hydroxyvitamin D level below 20 ng/mL (50 nmol/L) — affects an estimated 42% of US adults, with markedly higher prevalence among people with darker skin, older adults, individuals with obesity, and those living at higher latitudes with limited sun exposure. The National Health and Nutrition Examination Survey (NHANES) consistently identifies non-Hispanic Black Americans as having the highest deficiency prevalence, driven by increased melanin reducing cutaneous vitamin D synthesis. Because vitamin D is both synthesized in skin through UVB exposure and obtained from a small number of dietary sources, modern indoor lifestyles have made insufficiency the norm rather than the exception.
Optimal Levels and the Testing Debate
Clinical guidelines diverge on optimal targets. The Endocrine Society recommends a 25-hydroxyvitamin D level above 30 ng/mL for at-risk patients, while the Institute of Medicine considers 20 ng/mL adequate for bone health in the general population. The 2024 Endocrine Society clinical practice guideline notably shifted toward recommending against routine testing in healthy adults, reserving 25-hydroxyvitamin D measurement for those with specific risk factors — malabsorption syndromes, chronic kidney disease, osteoporosis, granulomatous disorders, and dark-skinned or institutionalized older adults. This reflects the reality that population-wide screening has not demonstrated outcome benefits in randomized trials.
Evidence-Based Supplementation
For confirmed deficiency, supplementation with 1,000-2,000 IU of vitamin D3 (cholecalciferol) daily is sufficient for most adults to reach adequate levels, with D3 demonstrating superior efficacy over D2 (ergocalciferol) at raising and maintaining serum concentrations. The large VITAL trial (25,871 participants) found that 2,000 IU daily did not reduce cardiovascular events or invasive cancer incidence in the general population — tempering enthusiasm for vitamin D as a preventive panacea — though secondary analyses suggested possible benefits for cancer mortality and autoimmune disease incidence. Healthcare facilities managing at-risk populations can source appropriate diagnostic testing supplies and nutritional supplements through our catalog.
